Organelle abnormalities in Alzheimer's disease
Organelle · 2025
DOI: 10.61747/0ifp.202503005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organelle, 2025. Verfasst von Ju Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common cause of dementia, pathologically characterized by extracellular amyloid plaques and intracellular neurofibrillary tangles. While these pathological hallmarks remain central to our understanding of AD, they do not fully explain the complex cellular failures observed throughout the disease course. Neurons are highly specialized and polarized cells that depend on an integrated and dynamic network of specialized subcellular compartments named organelles to maintain structure, metabolism, and communication. Given these critical roles, organelle dysfunction is increasingly recognized as a key contributor to AD pathogenesis. Structural and functional impairments in conventional organelles, including mitochondria, endoplasmic reticulum (ER), lysosomes, Golgi apparatus, and peroxisomes, are consistently observed in AD brains and experimental models. These impairments are believed to cause energy failure, disrupted proteostasis, intracellular trafficking defects, and elevated oxidative and ER stress. In parallel, abnormalities in membraneless organelles (MLOs) further compromise RNA regulation, protein synthesis, and cellular stress responses. Additionally, perturbed communication between organelles, such as at mitochondria-associated ER membranes (MAMs), lipid droplets, and primary cilia, further exacerbates signaling imbalances and neuronal vulnerability. In this review, we not only provide a comprehensive overview of abnormalities in both membrane-bound and membraneless organelles in AD, emphasizing how their dysfunction contributes to cellular stress, impaired homeostasis, and neurodegeneration, but also discuss how disruptions in organelles intersect with amyloid, tau, and other AD-associated pathologies to intensify disease progression. A deeper understanding of organelle dysfunction in AD may provide new mechanism insights and advance the development of effective disease modifying interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Gao, J., Vicuna, L., & Wang, X. (2025). Organelle abnormalities in Alzheimer's disease. Organelle. https://doi.org/10.61747/0ifp.202503005
Vancouver
Gao J, Vicuna L, Wang X. Organelle abnormalities in Alzheimer's disease. Organelle. 2025. doi:10.61747/0ifp.202503005
BibTeX
@article{Gao2025,
author = {Gao, Ju and Vicuna, Lauren and Wang, Xinglong},
title = {Organelle abnormalities in Alzheimer's disease},
journal = {Organelle},
year = {2025},
doi = {10.61747/0ifp.202503005}
}
EUVIMED